These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12424150)

  • 1. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    McComb JM; Camm AJ
    BMJ; 2002 Nov; 325(7372):1050-1. PubMed ID: 12424150
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide QRS, narrow QRS: what's the difference?
    Olshansky B
    J Am Coll Cardiol; 2005 Jul; 46(2):317-9. PubMed ID: 16022961
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the game.
    Sweeney MO
    J Cardiovasc Electrophysiol; 2005 May; 16(5):483-5. PubMed ID: 15877618
    [No Abstract]   [Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Updated ESC guideline: innovations for the treatment of ventricular arrhythmias and recommendations for prevention of sudden cardiac death].
    Eckardt L; Deneke T
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):288-94. PubMed ID: 27581243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wearable cardioverter-defibrillators.
    Adler A; Halkin A; Viskin S
    Circulation; 2013 Feb; 127(7):854-60. PubMed ID: 23429896
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
    Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
    Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current indications for an implantable cardioverter defibrillator (ICD)].
    Arenja N; Schaer B; Sticherling C; Kühne M
    Ther Umsch; 2014 Feb; 71(2):111-6. PubMed ID: 24463381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitachyarrhythmic interventions of implantable cardioverter-defibrillator in primary and secondary sudden cardiac death prevention patients].
    Piekarz J; Rydlewska A; Majewski J; Lelakowski J
    Pol Merkur Lekarski; 2012 Jun; 32(192):368-73. PubMed ID: 22891561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of sudden death and the countermeasures--implantable defibrillators].
    Kasanuki H
    Nihon Naika Gakkai Zasshi; 1998 Jan; 87(1):105-16. PubMed ID: 9513555
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.
    Prystowsky EN
    Rev Cardiovasc Med; 2001; 2(4):197-205. PubMed ID: 12439369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Raj SR; Mitchell LB; Sheldon RS
    N Engl J Med; 2000 Jul; 343(1):68-9. PubMed ID: 10896549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary prevention of sudden cardiac death through a wearable cardioverter-defibrillator].
    Gabrielli D; Benvenuto M; Baroni M; Oliva F; Capucci A
    G Ital Cardiol (Rome); 2015; 16(7-8):418-25. PubMed ID: 26228611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.
    Lim TS; Tan BY; Ho KL; Lim CY; Teo WS; Ching CK
    Singapore Med J; 2015 Oct; 56(10):580-5. PubMed ID: 26512151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nursing care for automatic implantable defibrillators].
    Pépin A; Samuel B; Kihel A
    Soins; 2006; (702 Suppl):S3-5. PubMed ID: 16493932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.